Alzheimer's Screening and Prevention Act of 2025 or the ASAP Act This bill provides for Medicare coverage of blood tests to screen for the early stages of Alzheimer’s disease or related dementias. Specifically, the bill provides for coverage of genomic sequencing blood or blood product tests, or other equivalent tests, that are approved by the Food and Drug Administration.
CRS summary — Introduced in House (2025-11-19)
